Corcept Therapeutics stock plunges after loss in patent battle with with Teva Dr_Microbe/iStock through Getty Photos Corcept Therapeutics (NASDAQ:CORT) plummeted 38% in after-hours buying and selling on Friday after a … January 2,2:34 AM By Team News Nation Live In Markets